BTS
XPH icon

BB&T Securities’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

BB&T Securities’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,893
Closed -$215K – 1656
2018
Q4 		$215K Sell
5,893
-400
-6% -$17.1K ﹤0.01% 1331
2018
Q3 		$305K Hold
6,293
– – ﹤0.01% 1316
2018
Q2 		$270K Sell
6,293
-6,657
-51% -$280K ﹤0.01% 1327
2018
Q1 		$542K Buy
12,950
+155
+1% +$6.75K 0.01% 986
2017
Q4 		$556K Hold
12,795
– – 0.01% 960
2017
Q3 		$544K Buy
12,795
+150
+1% +$6.36K 0.01% 956
2017
Q2 		$544K Buy
12,645
+1,232
+11% +$51.9K 0.01% 943
2017
Q1 		$477K Buy
+11,413
New +$465K 0.01% 902

Other funds holding XPH

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return